MacroGenics Provides Update on Corporate Progress and First Quarter 2022 Financial Results

Go back to MacroGenics Provides Update on Corporate Progress and First Quarter 2022 Financial Results

Macrogenics (MGNX) Misses Q1 EPS by 22c

May 3, 2022 4:42 PM EDT

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($1.08), $0.22 worse than the analyst estimate of ($0.86). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $21.44 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

... More